TLR2 and inflammation: Of note, prior studies revealed that in vivo DOX treatment increased TLR2 levels in cardiomyocytes [38] and inhibition of TLR2 activity improved cardiac dysfunction and inhibited cardiac fibrosis and myocardial inflammation [51].